http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107468657-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
filingDate 2016-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107468657-B
titleOfInvention Cefmetazole sodium pharmaceutical composition for injection
abstract The invention relates to a cefmetazole sodium composition for injection, which contains 99.1-99.75wt% of cefmetazole sodium sterile powder, 0.05-0.1% of sodium salicylate, 0.1-0.5% of glucose and 0.1-0.3% of vitamin C, wherein the cefmetazole sodium sterile powder is amorphous cefmetazole sodium. The invention also relates to the preparation of the amorphous cefmetazole sodium powder for injection, which is characterized in that cefmetazole sodium is heated and dissolved in a proper benign solvent water/N, N-dimethylacetamide mixed solution, and then is sterilized and filtered, the filtrate is dripped into an inert solvent butanone/ethanol mixture at a certain stirring speed and flow rate, and then is cooled, crystallized, filtered and dried to obtain the amorphous cefmetazole sodium sterile powder. The invention provides a preparation method of amorphous cefmetazole sodium sterile powder and a pharmaceutical composition containing the cefmetazole sodium, which overcomes the defects of poor stability and poor redissolution clarity of cefmetazole sodium for injection in the prior art and provides a new medication choice of cefmetazole sodium.
priorityDate 2016-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S61238725-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447475885
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23666711
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414855969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42008
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16760658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447864721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054

Total number of triples: 41.